Latest Share Chat

REMOVE ADS

Celadon Pharmaceuticals Share News (CEL)

Celadon Pharmaceuticals Information

This share is currently suspended. It was suspended at a price of 13.40

There is currently no data for CEL

REMOVE ADS

Celadon Pharmaceuticals News

LONDON MARKET CLOSE: Oil and gold lift FTSE 100 but mid-caps falter

(Alliance News) - London's FTSE 100 outperformed European peers on Monday as gains in commodity stocks offset weaker housebuilders and property issues...

Celadon shares slump on little progress in financing talks

(Alliance News) - Celadon Pharmaceuticals PLC on Monday said it has sufficient working capital to last through to January, but cautioned that talks ov...

AIM WINNERS & LOSERS: Judges Scientific down on "disappointing" trade

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

Celadon Pharmaceuticals signs sales contract with Valeos Pharma

(Alliance News) - Celadon Pharmaceuticals PLC on Wednesday announced it has signed a five-year sales contract with Valeos Pharma AS.

EXECUTIVE CHANGES: Bank of Ireland promotes ex-Barclays exec to chair

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and not separately ...

Celadon Pharmaceuticals finance chief to step down

(Sharecast News) - Celadon Pharmaceuticals announced on Monday that Jonathan Turner, its chief financial officer, was stepping down.

Celadon inks partnership with Denmark's Valeos

(Sharecast News) - Celadon Pharmaceuticals announced a strategic collaboration with Danish pharmaceutical company Valeos Pharma on Wednesday, to accel...

Celadon Pharmaceuticals shares dive as laments delayed funding

(Alliance News) - Celadon Pharmaceuticals PLC on Wednesday announced it raised money via a fundraise as is decried a funding delay, and announced a ne...